Alaunos Therapeutics, Inc.
TCRT· Nasdaq
Alaunos Therapeutics, Inc.
- Close
- Jun 30, 2026
- Market cap
- $5.62M
- 2.49M shares
- Filings
- 1,014
Price
Jun 30, 2026 · 13F quarter end
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $5,000 | reported | |
| FY 2024 | 2024-12-31 | $10,000 | reported | |
| FY 2023 | 2023-12-31 | $5,000 | reported | |
| FY 2022 | 2022-12-31 | $2,922,000 | reported | |
| FY 2021 | 2021-12-31 | $398,000 | reported | |
| FY 2020 | 2020-12-31 | $0 | reported | |
| FY 2018 | 2018-12-31 | $146,000 | reported | |
| FY 2017 | 2017-12-31 | $6,389,000 | reported | |
| FY 2016 | 2016-12-31 | $6,861,000 | reported | |
| FY 2012 | 2012-12-31 | $800,000 | reported | |
| FY 2011 | 2011-12-31 | $667,000 | reported |
Alaunos Therapeutics, Inc. · CIK 1107421 · Engraved from SEC EDGAR
